[1]
Luis Ignacio Casanova Peño et al. 2016. Clinical Data Associated With the Therapeutic Response to Glatiramer Acetate in Multiple Sclerosis Patients. Neuro. 3, 1 (Sep. 2016), 3–8. DOI:https://doi.org/10.17140/NOJ-3-121.